Procopio Anna Caterina, Colletta Simona, Laratta Emanuela, Mellace Matteo, Tilocca Bruno, Ceniti Carlotta, Urbani Andrea, Roncada Paola
Department of Health Sciences, University Magna Graecia of Catanzaro, viale Europa, 88100 Catanzaro, Italy.
Department of Diagnostic and Laboratory Medicine, Unity of Chemistry, Biochemistry and Clinical Molecular Biology, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
One Health. 2024 Jan 28;18:100684. doi: 10.1016/j.onehlt.2024.100684. eCollection 2024 Jun.
Zoonoses have rapidly spread globally, necessitating the implementation of vaccination strategies as a control measure. Emerging and re-emerging vector-borne diseases are among the major global public health concerns. Dengue, a zoonotic viral infection transmitted to humans by a vector, the mosquito, is a severe global health problem. Dengue is a serious tropical infectious disease, second only to malaria, causing around 25,000 deaths each year. The resurgence of Dengue is mainly due to climate change, demographic transitions and evolving social dynamics. The development of an effective vaccine against Dengue has proven to be a complex undertaking due to four different viral serotypes with distinct antigenic profiles. This review highlights the urgent need to address the dengue threat by exploring the application of biotechnological and -OMICS sciences.
人畜共患病已在全球迅速传播,因此有必要实施疫苗接种策略作为控制措施。新出现和再次出现的媒介传播疾病是全球主要的公共卫生问题。登革热是一种通过媒介蚊子传播给人类的人畜共患病毒感染,是一个严重的全球健康问题。登革热是一种严重的热带传染病,仅次于疟疾,每年造成约25000人死亡。登革热的再次流行主要归因于气候变化、人口结构转变和不断演变的社会动态。由于四种具有不同抗原特性的病毒血清型,开发一种有效的登革热疫苗已被证明是一项复杂的任务。本综述强调了通过探索生物技术和组学科学的应用来应对登革热威胁的迫切需要。